Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
SS-31 (Elamipretide) Peptide
Cardiolipin-targeting peptide studied for mitochondrial dysfunction.
What is SS-31 (Elamipretide)?
SS-31 (Elamipretide) is a mitochondrial peptide studied for heart failure with preserved ejection fraction and primary mitochondrial myopathy. Below is an educational overview of SS-31 (Elamipretide) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
SS-31 (Elamipretide) Mechanism of Action
A tetrapeptide that selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure, preserving electron transport efficiency, and reducing reactive oxygen species production.
SS-31 (Elamipretide) Research Areas & Benefits
SS-31 (Elamipretide) Dosage & Common Research Protocols
Investigated in once-daily subcutaneous regimens for mitochondrial myopathy and HFpEF.
Protocols summarized for educational reference from published research. Not dosing guidance.
SS-31 (Elamipretide) Studies & Cited Research
Elamipretide in primary mitochondrial myopathy (MMPOWER-3)
Did not meet primary endpoints but showed signals in subgroup analyses.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
SS-31 (Elamipretide) Side Effects & Safety Considerations
- •Investigational; not FDA-approved.
- •Injection-site reactions are common in trials.
Common questions about SS-31 (Elamipretide)
More Longevity peptides · See all 6
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.